Nanjing King-friend Biochemical Pharmaceutical Co., Ltd

Nanjing King-friend Biochemical Pharmaceutical Co., Ltd is a Shanghai Stock Exchange A-share listed enterprise (stock code SH.603707). At present, it is the world's largest heparin API manufacturer, and also the Chinese pharmaceutical company holding the largest injection ANDA in the United States. The products cover heparin raw materials, as well as various injection products used in cardiovascular, anesthesia, nerve and other fields.
The company has the world's leading isolator production line, high-end sterile injection production technology, as well as the global quality system certified by China, United States, Europe, Japan, Brazil and other regions.
With world-class production and R&D speed, global quality awareness and rooted sales ability in the United States, we can provide injection R&D, production, registration and sales integrated CDMO services with China US market as the core and covering the world, and help Chinese pharmaceutical enterprises to go global.